243 related articles for article (PubMed ID: 30076439)
21. Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model.
Daley E; Streeten EA; Sorkin JD; Kuznetsova N; Shapses SA; Carleton SM; Shuldiner AR; Marini JC; Phillips CL; Goldstein SA; Leikin S; McBride DJ
J Bone Miner Res; 2010 Feb; 25(2):247-61. PubMed ID: 19594296
[TBL] [Abstract][Full Text] [Related]
22. Osteogenesis imperfecta: Ultrastructural and histological findings on examination of skin revealing novel insights into genotype-phenotype correlation.
Balasubramanian M; Sobey GJ; Wagner BE; Peres LC; Bowen J; Bexon J; Javaid MK; Arundel P; Bishop NJ
Ultrastruct Pathol; 2016; 40(2):71-6. PubMed ID: 26863094
[TBL] [Abstract][Full Text] [Related]
23. Morphological and mechanical characterization of bone phenotypes in the Amish G610C murine model of osteogenesis imperfecta.
Kohler R; Tastad CA; Creecy A; Wallace JM
PLoS One; 2021; 16(8):e0255315. PubMed ID: 34449800
[TBL] [Abstract][Full Text] [Related]
24. Effect of rapamycin on bone mass and strength in the α2(I)-G610C mouse model of osteogenesis imperfecta.
Bateman JF; Sampurno L; Maurizi A; Lamandé SR; Sims NA; Cheng TL; Schindeler A; Little DG
J Cell Mol Med; 2019 Mar; 23(3):1735-1745. PubMed ID: 30597759
[TBL] [Abstract][Full Text] [Related]
25. 4PBA reduces growth deficiency in osteogenesis imperfecta by enhancing transition of hypertrophic chondrocytes to osteoblasts.
Scheiber AL; Wilkinson KJ; Suzuki A; Enomoto-Iwamoto M; Kaito T; Cheah KS; Iwamoto M; Leikin S; Otsuru S
JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34990412
[TBL] [Abstract][Full Text] [Related]
26. Hyperplastic callus formation in osteogenesis imperfecta.
Lehmann HW; Nerlich A; Brenner RE; Bodo M; Müller PK
Eur J Pediatr Surg; 1992 Oct; 2(5):281-4. PubMed ID: 1420073
[TBL] [Abstract][Full Text] [Related]
27. RNA-based bone histomorphometry: method and its application to explaining postpubertal bone gain in a G610C mouse model of osteogenesis imperfecta.
Makareeva E; Sousa M; Kent T; de Castro LF; Collins MT; Leikin S
J Bone Miner Res; 2024 Mar; 39(2):177-189. PubMed ID: 38477760
[TBL] [Abstract][Full Text] [Related]
28. Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients.
Zhytnik L; Maasalu K; Reimann E; Prans E; Kõks S; Märtson A
Hum Genomics; 2017 Aug; 11(1):19. PubMed ID: 28810924
[TBL] [Abstract][Full Text] [Related]
29. Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta.
Lindahl K; Åström E; Rubin CJ; Grigelioniene G; Malmgren B; Ljunggren Ö; Kindmark A
Eur J Hum Genet; 2015 Aug; 23(8):1042-50. PubMed ID: 25944380
[TBL] [Abstract][Full Text] [Related]
30. [A new mutation in COL1A1 gene in a family with osteogenesis imperfecta].
Wang Z; Xu DL; Chen Z; Hu JY; Yang Z; Wang LT
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(3):170-3. PubMed ID: 16638323
[TBL] [Abstract][Full Text] [Related]
31. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
Lindahl K; Kindmark A; Rubin CJ; Malmgren B; Grigelioniene G; Söderhäll S; Ljunggren Ö; Åström E
Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
[TBL] [Abstract][Full Text] [Related]
32. Correlations Between Bone Mechanical Properties and Bone Composition Parameters in Mouse Models of Dominant and Recessive Osteogenesis Imperfecta and the Response to Anti-TGF-β Treatment.
Bi X; Grafe I; Ding H; Flores R; Munivez E; Jiang MM; Dawson B; Lee B; Ambrose CG
J Bone Miner Res; 2017 Feb; 32(2):347-359. PubMed ID: 27649409
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice.
Wang L; Yu Y; Ni S; Li D; Liu J; Xie D; Chu HY; Ren Q; Zhong C; Zhang N; Li N; Sun M; Zhang ZK; Zhuo Z; Zhang H; Zhang S; Li M; Xia W; Zhang Z; Chen L; Shang P; Pan X; Lu A; Zhang BT; Zhang G
Theranostics; 2022; 12(13):5645-5674. PubMed ID: 35966595
[No Abstract] [Full Text] [Related]
34. Mutation analysis of the COL1A1 and COL1A2 genes in Vietnamese patients with osteogenesis imperfecta.
Ho Duy B; Zhytnik L; Maasalu K; Kändla I; Prans E; Reimann E; Märtson A; Kõks S
Hum Genomics; 2016 Aug; 10(1):27. PubMed ID: 27519266
[TBL] [Abstract][Full Text] [Related]
35. Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta.
Rauch F; Lalic L; Roughley P; Glorieux FH
J Bone Miner Res; 2010 Jun; 25(6):1367-74. PubMed ID: 19929435
[TBL] [Abstract][Full Text] [Related]
36. Skeletal dysplasia in perinatal lethal osteogenesis imperfecta. A complex disorder of endochondral and intramembranous ossification.
Marion MJ; Gannon FH; Fallon MD; Mennuti MT; Lodato RF; Kaplan FS
Clin Orthop Relat Res; 1993 Aug; (293):327-37. PubMed ID: 8339500
[TBL] [Abstract][Full Text] [Related]
37. Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix.
Mundlos S; Chan D; Weng YM; Sillence DO; Cole WG; Bateman JF
J Biol Chem; 1996 Aug; 271(35):21068-74. PubMed ID: 8702873
[TBL] [Abstract][Full Text] [Related]
38. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
Gajko-Galicka A
Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
[TBL] [Abstract][Full Text] [Related]
39. Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function.
Jeong Y; Daghlas SA; Kahveci AS; Salamango D; Gentry BA; Brown M; Rector RS; Pearsall RS; Phillips CL
Muscle Nerve; 2018 Feb; 57(2):294-304. PubMed ID: 28555931
[TBL] [Abstract][Full Text] [Related]
40. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.
Marini JC; Forlino A; Cabral WA; Barnes AM; San Antonio JD; Milgrom S; Hyland JC; Körkkö J; Prockop DJ; De Paepe A; Coucke P; Symoens S; Glorieux FH; Roughley PJ; Lund AM; Kuurila-Svahn K; Hartikka H; Cohn DH; Krakow D; Mottes M; Schwarze U; Chen D; Yang K; Kuslich C; Troendle J; Dalgleish R; Byers PH
Hum Mutat; 2007 Mar; 28(3):209-21. PubMed ID: 17078022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
